I think the upside movement will continue. It's not too late to enter a long position.
On macro perspective the company will launch its phase 3 final trial next week. So far 2/3 have been completed for its NVX-CoV2373 vaccine.
On technical side the prices are shaping a . Aggressive buyers would have bought earlier but more than 20% can still be earned.
The 4h DMI keeps climbing. Current levels are 26 maybe go to 39 or more.
Let's see ...